Covid19cle
Share
You may be eligible to join a clinical trial at CWRU/UH to see if various early-infection treatments for the SARS-CoV-2 virus may lessen the severity of COVID-19. 18+, must enroll within 7 days of positive coronavirus test.
09/26/2022
COVID-19 is still a global pandemic, despite what the president says. If you have a recent case (last 10 days), please consider volunteering for an observational study with us. Compensation provided. Call 216-844-4444. Thank you.
07/14/2022
"Our study suggests that as these highly transmissible subvariants continue to expand around the globe, they will lead to more breakthrough infections in people who are vaccinated and boosted with currently available mRNA vaccines," Ho said.
Newest Omicron subvariants can evade boosters and antibody therapies
Newest Omicron subvariants can evade boosters, antibody therapies BA.4 and BA.5—which now cause more than 70% of US cases—are 4 times more resistant to 3 vaccine doses than BA.2 is, and only 1 of 19 monoclonal antibodies tested showed efficacy against those subvariants.
Click here to claim your Sponsored Listing.
